Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis
Antioxidants · 20.11.2026 · 15 (11) · 1517
DOI: 10.3390/antiox15111517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.11.2026. Verfasst von Po-Yu Huang und 7 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University Hospital, Buddhist Tzu Chi Medical Foundation.
Abstract (Originalsprache)
Background
Renal tubulointerstitial fibrosis, a hallmark of chronic kidney disease (CKD), involves epithelial–mesenchymal transition (EMT), oxidative stress, and ferroptosis. This study investigated the renoprotective effects of isovitexin (ISOV) and its underlying molecular mechanisms. Materials and Methods: Male mice subjected to unilateral ureteral obstruction (UUO) were orally administered ISOV, while NRK52E cells were exposed to indoxyl sulfate (IS) with or without ISOV. Renal injury and molecular alterations were assessed using histopathology, immunohistochemistry, Western blotting, RT-qPCR, and immunofluorescence. Reactive oxygen species (ROS), lipid peroxidation, and intracellular ferrous iron were evaluated using flow cytometry, malondialdehyde assays, and FerroOrange staining, respectively. RNA sequencing, public single-cell RNA sequencing datasets, and molecular docking were employed to identify molecular targets IL-7 expression, and predict ISOV–IL-7 interactions.
Results
ISOV significantly attenuated renal fibrosis, tubular injury, and EMT-associated markers. ISOV significantly attenuated IS-induced ROS accumulation, lipid peroxidation and intracellular ferrous iron (Fe2+) accumulation. Single-cell RNA sequencing analysis revealed elevated IL-7 expression in proximal tubular cells from CKD kidneys. Molecular docking predicted a potential interaction between ISOV and IL-7. Furthermore, ISOV suppressed IL-7 expression and AKT/mTOR phosphorylation, whereas IL-7 knockdown alleviated ferroptotic injury in NRK52E cells, suggesting that IL-7 contributes to the regulation of AKT/mTOR signaling and ferroptotic cell injury.
Conclusions
ISOV exerts protective effects against renal tubulointerstitial fibrosis, potentially through suppression of the IL-7/AKT/mTOR signaling axis and ferroptosis, supporting its therapeutic potential for CKD-associated renal fibrosis.
Förderung
- Chung Shan Medical University Hospital
- Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Huang, P., Hung, T., Tsai, P., Ting, Y., Lee, Y., Chen, Y., Tsai, J., & Hsieh, Y. (2026). Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis. Antioxidants, 15(11), 1517. https://doi.org/10.3390/antiox15111517
Vancouver
Huang P, Hung T, Tsai P, Ting Y, Lee Y, Chen Y, et al. Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis. Antioxidants. 2026;15(11):1517. doi:10.3390/antiox15111517
BibTeX
@article{Huang2026,
author = {Huang, Po-Yu and Hung, Tung-Wei and Tsai, Po-Yu and Ting, Yi-Hsuan and Lee, Yu-Hsun and Chen, Yong-Syuan and Tsai, Jen-Pi and Hsieh, Yi-Hsien},
title = {Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1517},
doi = {10.3390/antiox15111517}
}
EUVIMED